Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist that shares approximately 94% structural homology with native human GLP-1. Originally developed as a long-acting analogue with enhanced resistance to dipeptidyl peptidase-4 (DPP-4) degradation, semaglutide has become one of the most extensively researched peptides in the fields of metabolic disease, obesity biology, and cardiovascular health.
As a GLP-1 receptor agonist, semaglutide exerts its effects by binding to and activating GLP-1 receptors, stimulating glucose-dependent insulin secretion, suppressing glucagon release, and slowing gastric emptying. Research has also highlighted its role in hypothalamic appetite regulation, making it a subject of significant interest in satiety and energy homeostasis studies.
This 10mg research vial of semaglutide is supplied as a lyophilised powder with a purity of >98%, as verified by HPLC analysis. Molecular formula: C₁₈₇H₂₉₁N₄₅O₅₉. Molecular weight: 4,113.58 g/mol. CAS number: 910463-68-2.
For optimal stability, store lyophilised semaglutide at -20°C, protected from light and moisture. Once reconstituted, store at 4°C and use within 28 days.
Molecular Formula
C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight
4113.58 g/mol
Purity
>98%
CAS Number
910463-68-2
Form
Lyophilised Powder
Research Applications
Metabolic disease research, Obesity and appetite regulation, Glycaemic control studies, Cardiovascular biology, GLP-1 receptor signalling, Neuroprotection and CNS research
For research purposes only. Not for human use.
Reviews
There are no reviews yet.